Overview of ESGO 2011
14 Oct 2011
Overview of ESGO 2011
Roundup of the EMCC 2011 conference
Olaparib extends PFS in women with high-grade serous ovarian cancer
4HBR chemoprevention in BRCA positive women
Genetic mutations as causes of cancer
Personalised medicine and cancer control in India
Improving pre-clinical experimental models to test anti cancer drugs
The P-Medicine project; data sharing and integration for personalised medicine
Treatment options for ovarian cancer
Standard of care for ovarian cancer
Ovarian cancer developments
Olaparib maintenance therapy for ovarian cancer and updates from ICON7